Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B06 OTHER HEMATOLOGICAL AGENTS
B06A OTHER HEMATOLOGICAL AGENTS
B06AC Drugs used in hereditary angioedema
B06AC08 Sebetralstat
D12396 Sebetralstat (JAN/USAN/INN) <US>
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D12396 Sebetralstat
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D12396 Sebetralstat
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
KLKB1
D12396 Sebetralstat (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12396
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12396
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D12396